238 related articles for article (PubMed ID: 15746991)
21. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
Greenspan SL; Parker RA; Ferguson L; Rosen HN; Maitland-Ramsey L; Karpf DB
J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
[TBL] [Abstract][Full Text] [Related]
22. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
23. Treatment with the oral growth hormone secretagogue MK-677 increases markers of bone formation and bone resorption in obese young males.
Svensson J; Ohlsson C; Jansson JO; Murphy G; Wyss D; Krupa D; Cerchio K; Polvino W; Gertz B; Baylink D; Mohan S; Bengtsson BA
J Bone Miner Res; 1998 Jul; 13(7):1158-66. PubMed ID: 9661080
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters.
Arlot M; Meunier PJ; Boivin G; Haddock L; Tamayo J; Correa-Rotter R; Jasqui S; Donley DW; Dalsky GP; Martin JS; Eriksen EF
J Bone Miner Res; 2005 Jul; 20(7):1244-53. PubMed ID: 15940379
[TBL] [Abstract][Full Text] [Related]
25. Relationship of bone turnover to bone density and fractures.
Melton LJ; Khosla S; Atkinson EJ; O'Fallon WM; Riggs BL
J Bone Miner Res; 1997 Jul; 12(7):1083-91. PubMed ID: 9200008
[TBL] [Abstract][Full Text] [Related]
26. Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk.
Reginster JY; Sarkar S; Zegels B; Henrotin Y; Bruyere O; Agnusdei D; Collette J
Bone; 2004 Feb; 34(2):344-51. PubMed ID: 14962813
[TBL] [Abstract][Full Text] [Related]
27. Association of bone metabolism related genes polymorphisms with the effect of raloxifene hydrochloride on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis.
Zhang ZL; He JW; Qin YJ; Huang QR; Liu YJ; Hu YQ; Li M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):129-33. PubMed ID: 16604479
[TBL] [Abstract][Full Text] [Related]
28. Effect of dietary supplementation with conjugated linoleic acid on markers of calcium and bone metabolism in healthy adult men.
Doyle L; Jewell C; Mullen A; Nugent AP; Roche HM; Cashman KD
Eur J Clin Nutr; 2005 Mar; 59(3):432-40. PubMed ID: 15674313
[TBL] [Abstract][Full Text] [Related]
29. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.
Marcus R; Holloway L; Wells B; Greendale G; James MK; Wasilauskas C; Kelaghan J
J Bone Miner Res; 1999 Sep; 14(9):1583-95. PubMed ID: 10469288
[TBL] [Abstract][Full Text] [Related]
30. The vitamin D analogue 2MD increases bone turnover but not BMD in postmenopausal women with osteopenia: results of a 1-year phase 2 double-blind, placebo-controlled, randomized clinical trial.
DeLuca HF; Bedale W; Binkley N; Gallagher JC; Bolognese M; Peacock M; Aloia J; Clagett-Dame M; Plum L
J Bone Miner Res; 2011 Mar; 26(3):538-45. PubMed ID: 20890933
[TBL] [Abstract][Full Text] [Related]
31. Dose-response relationships between energy availability and bone turnover in young exercising women.
Ihle R; Loucks AB
J Bone Miner Res; 2004 Aug; 19(8):1231-40. PubMed ID: 15231009
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of 41calcium as a new approach to assess changes in bone metabolism: effect of a bisphosphonate intervention in postmenopausal women with low bone mass.
Denk E; Hillegonds D; Hurrell RF; Vogel J; Fattinger K; Häuselmann HJ; Kraenzlin M; Walczyk T
J Bone Miner Res; 2007 Oct; 22(10):1518-25. PubMed ID: 17576167
[TBL] [Abstract][Full Text] [Related]
33. Single-dose, randomized, double-blind, placebo-controlled study of ACE-011 (ActRIIA-IgG1) in postmenopausal women.
Ruckle J; Jacobs M; Kramer W; Pearsall AE; Kumar R; Underwood KW; Seehra J; Yang Y; Condon CH; Sherman ML
J Bone Miner Res; 2009 Apr; 24(4):744-52. PubMed ID: 19049340
[TBL] [Abstract][Full Text] [Related]
34. The effect of D-003 (10 mg/day) on biochemical parameters of bone remodelling in postmenopausal women: a randomized, double-blind study.
Ceballos A; Mas R; Castaño G; Fernández L; Mendoza S; Menéndez R; González JJ; Illnait J; Gámez R; Mesa M; Fernández J
Int J Clin Pharmacol Res; 2005; 25(4):175-86. PubMed ID: 16402634
[TBL] [Abstract][Full Text] [Related]
35. Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody.
Padhi D; Jang G; Stouch B; Fang L; Posvar E
J Bone Miner Res; 2011 Jan; 26(1):19-26. PubMed ID: 20593411
[TBL] [Abstract][Full Text] [Related]
36. L-arginine, the natural precursor of NO, is not effective for preventing bone loss in postmenopausal women.
Baecker N; Boese A; Schoenau E; Gerzer R; Heer M
J Bone Miner Res; 2005 Mar; 20(3):471-9. PubMed ID: 15746992
[TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover.
Tankó LB; Bagger YZ; Alexandersen P; Devogelaer JP; Reginster JY; Chick R; Olson M; Benmammar H; Mindeholm L; Azria M; Christiansen C
J Bone Miner Res; 2004 Sep; 19(9):1531-8. PubMed ID: 15312255
[TBL] [Abstract][Full Text] [Related]
38. Short-term risedronate treatment in postmenopausal women: effects on biochemical markers of bone turnover.
Raisz L; Smith JA; Trahiotis M; Fall P; Shoukri K; Digennaro J; Sacco-Gibson N
Osteoporos Int; 2000; 11(7):615-20. PubMed ID: 11069196
[TBL] [Abstract][Full Text] [Related]
39. Low-dose fluoride in postmenopausal women: a randomized controlled trial.
Grey A; Garg S; Dray M; Purvis L; Horne A; Callon K; Gamble G; Bolland M; Reid IR; Cundy T
J Clin Endocrinol Metab; 2013 Jun; 98(6):2301-7. PubMed ID: 23553866
[TBL] [Abstract][Full Text] [Related]
40. A randomized trial of nasal spray salmon calcitonin in men with idiopathic osteoporosis: effects on bone mineral density and bone markers.
Trovas GP; Lyritis GP; Galanos A; Raptou P; Constantelou E
J Bone Miner Res; 2002 Mar; 17(3):521-7. PubMed ID: 11874243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
